NKGen Biotech (NKGN) Institutional Ownership → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free NKGN Stock Alerts $1.35 +0.06 (+4.65%) (As of 05/8/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$1.54MNumber ofInstitutional Sellers(last 12 months)0 Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/1/2024 Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070% 3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward) NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: University of Chicago ($1.51M), Sequoia Financial Advisors LLC ($30K).Learn more on NKGN's institutional investors. What percentage of NKGen Biotech stock is owned by institutional investors? 76.17% of NKGen Biotech stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech stock? The following institutional investors have purchased NKGen Biotech stock in the last 24 months: University of Chicago ($550K), and Sequoia Financial Advisors LLC ($16K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 566,000 shares in the last 24 months. This purchase volume represents approximately $1.54M in transactions. Related Companies: Pluri Major Shareholders Surrozen Major Shareholders MiNK Therapeutics Major Shareholders Protara Therapeutics Major Shareholders Brainstorm Cell Therapeutics Major Shareholders Achilles Therapeutics Major Shareholders ZIVO Bioscience Major Shareholders Evaxion Biotech A/S Major Shareholders Estrella Immunopharma Major Shareholders SAB Biotherapeutics Major Shareholders This page (NYSE:NKGN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe #1 Crypto for AIWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.